From: Travel risk behaviors as a determinants of receiving pre-travel health consultation and prevention
Preventive measures | Total | Asia | Africa | S. America | Others | |||||
---|---|---|---|---|---|---|---|---|---|---|
No | % | No | % | No | % | No | % | No | % | |
755 | 100 | 196 | 100 | 355 | 100 | 76 | 100 | 128 | 100 | |
• Yellow Fever | 431 | 57.1 | - | - | 355 | 100 | 76 | 100 | - | - |
• ACWY meningococcal vaccine | 685 | 90.7 | 193 | 98.4 | 348 | 98.0 | 63 | 82.9 | 81 | 63.3 |
• Typhoid | 246 | 32.6 | 103 | 52.6 | 112 | 31.5 | 31 | 40.8 | - | - |
• Tetanus | 311 | 41.2 | 73 | 37.2 | 213 | 60.0 | 25 | 32.9 | - | - |
• Influenza | 122 | 16.2 | 40 | 20.4 | - | - | 21 | 27.6 | 61 | 47.7 |
• Malaria Drugs | ||||||||||
- Mefloquine | 383 | 50.7 | 139 | 70.9 | 201 | 56.6 | 43 | 56.6 | - | - |
- Vibramycin | 201 | 26.6 | 14 | 07.1 | 154 | 43.4 | 33 | 43.4 | - | - |
• Health Education | ||||||||||
- General HE message | 723 | 95.7 | 193 | 98.4 | 355 | 100 | 76 | 100 | 99 | 77.3 |
- Specific HE message | 577 | 76.4 | 160 | 81.6 | 312 | 87.9 | 43 | 56.6 | 62 | 48.4 |